Further studies on the biological characteristics of an endogenous colon mitosis inhibitor: comparison with some structurally related peptides.
Previous work indicates that the colonic epithelial cell proliferation in mice is reversibly inhibited by the tripeptide pGlu-His-GlyOH found in aqueous extracts of the intestine. In the present study we examined the possible tissue specificity of the colon mitosis inhibitor. The mitotic rate in the small intestine, epidermis and forestomach in mice was registered after a single i.p. injection of the tripeptide. A significantly reduced rate of cell renewal was found at 18 h in the epidermis whereas no inhibition was observed in the forestomach or ileal epithelium. To investigate whether the amino acid sequence of the tripeptide is essential for the inhibitory effect, three structurally related bioactive peptides were tested and compared to the effect of CMI. CMI showed a bell-shaped dose-response relationship as previously shown, whereas the mitotic rate was not reduced in the colonic epithelium after treatment with either an epidermal mitosis inhibitory pentapeptide, or the dipeptide pGlu-GlyOH, or an analogue of luteinizing hormone-releasing hormone. The efficacy of the tripeptide was dependent on the basal rate of cell renewal in the colonic epithelium. When the tripeptide was given at the circadian nadir of cell proliferation a delayed reduction of proliferative activity was observed at 6 h after treatment, whereas treatment when the rate of cell proliferation was at its circadian zenith gave an immediate mitotic inhibition.
Skraastad
O
O
Institute of Pathology, Rikshospitalet, Oslo, Norway.
Reichelt
K L
KL
D000818:Animals; D001067:Appetite Depressants / Q000032:analysis*; D002940:Circadian Rhythm / Q000187:drug effects; D003106:Colon / Q000166:cytology / Q000187:drug effects*; D003703:Demecolcine / Q000494:pharmacology; D000078404:Epidermal Cells; D004817:Epidermis / Q000187:drug effects; D051379:Mice; D008812:Mice, Hairless; D008938:Mitosis / Q000187:drug effects; D009842:Oligopeptides / Q000032:analysis*; D010455:Peptides / Q000032:analysis*; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives
D001067:Appetite Depressants; D009842:Oligopeptides; D010455:Peptides; C023866:pyroglutamyl-histidyl-glycine; D011761:Pyrrolidonecarboxylic Acid; D003703:Demecolcine